
Imanib 100mg Capsule
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Imatinib mesylate (100mg)
Overview Imanib 100mg Capsule
Gleevec 100mg capsules are indicated for various cancers. Primarily prescribed for hematologic malignancies (chronic myeloid leukemia and acute lymphoblastic leukemia) and gastrointestinal stromal tumors (GIST), it acts by inhibiting specific proteins crucial for cancer cell proliferation and metastasis. It's also employed in dermatofibrosarcoma protuberans and aggressive systemic mastocytosis. Administer with food, consistently at the same time daily for optimal efficacy. Continue treatment as directed by your physician; duration is individualized. Incorrect or excessive use can lead to severe adverse events. Therapeutic benefits may take weeks or months to manifest; do not discontinue without medical guidance. Frequent side effects encompass edema, nausea, emesis, myalgia, musculoskeletal pain, diarrhea, skin rash, lassitude, and abdominal discomfort. Report sudden, significant weight gain immediately. Regular blood counts and liver function tests may be recommended. Avoid activities requiring alertness if dizziness or blurred vision occurs. Inform your healthcare provider of all concomitant medications, as significant interactions are possible. This medication is contraindicated in pregnancy and lactation; reliable contraception is essential for both partners during treatment.
Primary Ingredients of Imanib 100mg Capsule
No text provided. Please provide the text you want me to rephrase.
Uses of Imanib 100mg Capsule
Oncological Management
Major Benefits of Imanib 100mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume each 100mg Imanib capsule with a meal.
Common Side effects of Imanib 100mg Capsule:
- Edema (swelling)
- Nausea
- Vomiting
- Muscle cramp
- Musculoskeletal (bone, muscle or joint) pain
- Diarrhea
- Rash
- Fatigue
- Abdominal pain
- Bleeding
- Breathing problems
- Cough
- Weight gain
- Dry eye
- Dizziness
- Hemorrhage
How to use Imanib 100mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume the Imanib 100mg Capsule with a meal.
How Imanib 100mg Capsule works:
Imatinib mesylate 100mg capsules are a cancer treatment. They target the bcr-abl tyrosine kinase, a protein enzyme driving uncontrolled cancer cell growth. The drug's mechanism involves suppressing the proliferation of, and triggering programmed cell death (apoptosis) in, bcr-abl-positive cancerous cells, thus hindering or slowing cancer progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imanib 100mg Capsules may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Imatinib 100mg capsules during pregnancy poses a confirmed risk to the unborn child. Therefore, it's contraindicated. Nevertheless, a physician might exceptionally prescribe it in critical, life-threatening circumstances where the potential advantages outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Imanib 100mg capsules is likely unsafe. Available evidence indicates potential drug transfer to breast milk, posing a risk to the infant. Mothers should discontinue breastfeeding during Imanib treatment and for two weeks following its cessation.
DrivingUNSAFE
Driving ability may be impaired by the use of Imanib 100mg capsules, which can produce adverse reactions.
KidneyCAUTION
Patients with impaired kidney function should use Imanib 100mg capsules cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Imanib 100mg capsules cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Imanib 100mg Capsule :
Omit any missed Imanib 100mg Capsule and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Imanib 100mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Benzanilide derivative |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
